This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Exercise Controls Tumor Cell Growth Through AMPK Activation

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2013 by Inge Holm, Rigshospitalet, Denmark.
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
Inge Holm, Rigshospitalet, Denmark Identifier:
First received: June 16, 2011
Last updated: November 28, 2013
Last verified: November 2013
The study investigates the explanation for the positive relation found between exercise and breastcancer.

Breast Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Running From Cancer

Resource links provided by NLM:

Further study details as provided by Inge Holm, Rigshospitalet, Denmark:

Biospecimen Retention:   Samples Without DNA
Bloodsamples wherefrom, serum is isolated and kept at -20 degrees celsius

Estimated Enrollment: 10
Study Start Date: March 2011
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 30 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy Danish females in the age 18-30

Inclusion Criteria:

  • Healthy Females age 18-30
  • BMI 18-25
  • Regular period

Exclusion Criteria:

  • Ingestions of any hormones
  • Pregnancy
  • Chronic inflammation
  • Elite athletes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01376583

Centre of Inflammation and Metabolism Recruiting
Copenhagen, Denmark, 2100
Contact: Grith W Højfeldt, BSc   
Principal Investigator: Grith W Højfeldt, BSc         
Sponsors and Collaborators
Rigshospitalet, Denmark
Study Director: Bente K Pedersen, Professor Centre of Inflammation and Metabolism
  More Information

Responsible Party: Inge Holm, Administrator, Rigshospitalet, Denmark Identifier: NCT01376583     History of Changes
Other Study ID Numbers: VEK-H-3-2010-141
Study First Received: June 16, 2011
Last Updated: November 28, 2013

Keywords provided by Inge Holm, Rigshospitalet, Denmark:
Breast cancer
AMPK processed this record on August 18, 2017